Everett, MA, United States of America

Anna Liang

USPTO Granted Patents = 4 

Average Co-Inventor Count = 17.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Anna Liang

Introduction

Anna Liang is a prominent inventor based in Everett, MA (US), known for her significant contributions to the field of medical innovations. With a total of four patents to her name, she has made strides in developing treatments for autoimmune and metabolic disorders. Her work reflects a commitment to advancing healthcare through innovative solutions.

Latest Patents

Among her latest patents, one focuses on acylated active agents and methods for their use in treating autoimmune disorders. This patent discloses acylated active agents that can modulate autoimmunity markers or treat various autoimmune conditions. Another notable patent involves active agents and methods for treating metabolic disorders and nonalcoholic fatty liver disease. This patent outlines compositions and unit dosage forms aimed at addressing metabolic disorders and improving health outcomes for individuals suffering from nonalcoholic fatty liver disease.

Career Highlights

Anna Liang is currently associated with Flagship Pioneering Innovations V, Inc., where she continues to push the boundaries of medical research and innovation. Her work is characterized by a focus on developing effective treatments that can significantly improve patient care and health management.

Collaborations

Throughout her career, Anna has collaborated with esteemed colleagues, including Steven John Taylor and Mi-Jeong Kim. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the medical field.

Conclusion

Anna Liang's contributions to the field of medical innovations are noteworthy, as she continues to develop groundbreaking treatments for complex health issues. Her dedication to research and collaboration exemplifies the spirit of innovation in the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…